Economic evaluation of fractional exhaled nitric oxide (FENO) for the management of adult asthma in Spain Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015
Associations between fractional exhaled nitric oxide (FeNO), asthma, respiratory symptoms and self-reported allergies in female university students in Kobe, Japan Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015
The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015
Exhaled nitric oxide, susceptibility and new-onset asthma in the Children’s Health Study Source: Eur Respir J 2011; 37: 523-531 Year: 2011
Positive relationship between offline exhaled nitric oxide and lung clearance index in pre-school wheezers Source: International Congress 2014 – Paediatric asthma: lung function testing and more Year: 2014
Exhaled nitric oxide and the risk of wheezing in infancy: the Generation R Study Source: Eur Respir J 2012; 39: 567-572 Year: 2012
Fractional exhaled nitrogen oxide (FeNO), asthma, respiratory symptoms and self-reported allergy among high school students in Penang, Malaysia Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013
Association between nitric oxide and clinical phenotype in children with CF Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008
Factors associated with implausible estimates of alveolar nitric oxide concentration Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014
Concomitant use of fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) as markers for predicting asthma exacerbation Source: International Congress 2014 – Asthma: clinical problems Year: 2014
Combined value of exhaled nitric oxide and blood eosinophils in chronic airway disease: the Copenhagen General Population Study Source: Eur Respir J, 52 (2) 1800616; 10.1183/13993003.00616-2018 Year: 2018
Exhaled nitric oxide (FeNO) levels to guide treatment for children with asthma: A Cochrane systematic review Source: International Congress 2016 – Techniques and tools in paediatric asthma Year: 2016
Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) for predicting short-term treatment effect Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016
Inflammatory patterns in asthmatic children based on the measurement of alveolar nitric oxide Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013
Reference values for offline exhaled and nasal nitric oxide in healthy children Source: Annual Congress 2013 –Assessing sleep disordered breathing and lung function in children Year: 2013
Correlation of fractional exhaled nitric oxide (FeNO) and peripheral blood eosinophils (PBE) in refractory asthma Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014
Exhaled nitric oxide (FeNO), asthmatic symptoms and respiratory infections among junior high school students in Penang, Malaysia, in relation to fungal DNA in settled dust in schools Source: Annual Congress 2013 –Indoor and outdoor pollutants: ventilation, sprays, diesel particles, asthma and COPD Year: 2013
Meta-analysis of the accuracy of screening adult asthma using exhaled nitric oxide Source: Annual Congress 2013 –Studies of asthma in man Year: 2013
Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016
Alveolar nitric oxide and its role in asthma control assessment Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013